MTOR and prostate carcinoma: Inhibitors of the mitochondrial unfolded protein response targeting HSPD1 induced accumulation and metabolic stress of polyubiquitinated proteins, thereby inhibiting AKT/mTOR signaling in prostate cancer 59.